Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Omeros reports additional data from phase I OMS-824 program

Oct. 18, 2013

New drug combination for Parkinson's disease allows lower doses with enhanced clinical effects

Oct. 18, 2013

Stimulation of developmental pathways to reverse structural and cognitive deficits in trisomy 21

Oct. 18, 2013

Taiho Pharmaceutical synthesizes new vasopressin receptor antagonists

Oct. 17, 2013

Scientists at EnVivo Pharmaceuticals patent novel PDE9A inhibitors

Oct. 17, 2013

Esteve reports data from phase II study of E-58425 in acute pain

Oct. 17, 2013

Medical Developments submits MAA in Europe for penthrox

Oct. 16, 2013

QRxPharma expands MoxDuo agreement with Aspen Pharmacare

Oct. 16, 2013

Alcobra presents new findings on MG-01CI

Oct. 15, 2013

Anxiolytic activity demonstrated for RU-476

Oct. 15, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...